Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDKiromic BioPharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Kiromic BioPharma, Inc. Earnings Date And Information
Kiromic BioPharma, Inc. last posted its earnings results on Monday, March 18th, 2024. The company reported $-4.16 earnings per share for the quarter, topping analysts' consensus estimates of $-14.7 by $10.54. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Kiromic BioPharma, Inc. has generated $-1 earnings per share over the last year ($-1.03 diluted earnings per share) and currently has a price-to-earnings ratio of -1.34. Kiromic BioPharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Kiromic BioPharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/14/2025 | Q4 2024 | N/A | -$0.31 | N/A | N/A | $0 |
| 11/08/2024 | Q3 2024 | N/A | -$0.31 | N/A | $0 | $0 |
| 08/09/2024 | Q2 2024 | N/A | -$4.59 | N/A | $0 | $0 |
| 05/10/2024 | Q1 2024 | N/A | -$4.71 | N/A | N/A | $0 |
| 03/21/2024 | Q4 2023 | N/A | -$4.27 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$3.52 | N/A | N/A | $0 |
| 08/14/2023 | Q2 2023 | -$10.20 | -$6.42 | 3.78 | N/A | $0 |
| 05/15/2023 | Q1 2023 | -$16.80 | -$7.18 | 9.62 | N/A | $0 |
| 04/28/2023 | Q4 2022 | N/A | -$11.61 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$0.56 | -$22.63 | -22.07 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$12.31 | -$16.09 | -3.78 | N/A | $0 |
| 05/13/2022 | Q1 2022 | N/A | -$14.23 | N/A | N/A | $0 |
| 04/08/2022 | Q4 2021 | -$261.00 | -$20.55 | 240.45 | N/A | $0 |
| 03/11/2022 | Q3 2021 | N/A | -$11.96 | N/A | N/A | $0 |
| 08/13/2021 | Q2 2021 | N/A | -$20.32 | N/A | N/A | $0 |
| 05/14/2021 | Q1 2021 | N/A | -$15.77 | N/A | N/A | $0 |
| 03/31/2021 | Q4 2020 | N/A | -$14.58 | N/A | N/A | $0 |
| 11/30/2020 | Q3 2020 | N/A | -$10.01 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$47.12 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$14.33 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kiromic BioPharma, Inc. Earnings: FAQ's
Kiromic BioPharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based offlast year's report dates.
In the previous quarter, Kiromic BioPharma, Inc. (:KRBP) reported $-4.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-14.7 by $10.54.
The conference call for Kiromic BioPharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Kiromic BioPharma, Inc.'s latest earnings report can be read online.
Kiromic BioPharma, Inc. (:KRBP) has a recorded net income of $-26,898,000.Kiromic BioPharma, Inc. has generated $-1.03 earnings per share over the last four quarters.
Kiromic BioPharma, Inc. (:KRBP) has a price-to-earnings ratio of -1.34 and price/earnings-to-growth ratio is -0.05.